U.S. Software Stock News

NasdaqGS:AMD
NasdaqGS:AMDSemiconductor

AMD Stock And 2 US Tech Picks With Strong Margins

US large cap technology stocks are sitting at the crossroads of powerful forces right now. A sharp 19% S&P 500 surge in two months, strong Q1 earnings growth and rising inflation with possible Fed rate hikes are pulling market sentiment in different directions. For investors, the question is which individual stocks appear well placed, or potentially vulnerable, to this mix of stronger profits and tighter policy. This article walks through three US technology stocks from our screener that...
NYSE:PNR
NYSE:PNRMachinery

Pentair (PNR) Stock Could Be 26.5% Undervalued As AI Data Center Demand Sharpens Its Water Role

Pentair’s data center role puts water infrastructure in focus Pentair (PNR) is back in the spotlight after being highlighted as a key water infrastructure stock, with its Aurora pump portfolio tied directly to cooling and circulation needs in AI data centers. The attention on Pentair’s Flow segment, where the pump business sits, comes as investors reassess how water management companies might fit into the build out of hyperscale and edge computing facilities. See our latest analysis for...
NYSE:ROK
NYSE:ROKElectrical

Rockwell Automation (ROK) Stock Could Be 3% Overvalued After FactoryTalk ResilientEdge Launch

Rockwell Automation (ROK) is getting fresh attention after launching its FactoryTalk ResilientEdge platform, a new execution architecture that supports autonomous, scalable manufacturing operations and ties directly into the company’s broader digital and capacity investment plans. See our latest analysis for Rockwell Automation. Rockwell Automation’s recent FactoryTalk ResilientEdge rollout comes on top of a strong period for the stock, with a 90 day share price return of 33.42% and a 1 year...
NasdaqGS:CPRT
NasdaqGS:CPRTCommercial Services

Copart (CPRT) Stock Could Be 31% Overvalued After Fund Exit Over Weaker Fundamentals

Renaissance Investment Management recently exited its position in Copart (CPRT), citing deteriorating fundamentals as rising automotive insurance costs lead some consumers to drop collision coverage and reduce the supply of damaged vehicles entering Copart’s auctions. See our latest analysis for Copart. Despite the recent exit by Renaissance Investment Management, Copart’s share price has softened, with the 30 day share price return down 12.12% and the year to date share price return down...
NasdaqGS:PLTK
NasdaqGS:PLTKEntertainment

Is Playtika (PLTK) Turning Portfolio Refreshes and Institutional Interest Into a More Durable Profit Story?

In recent weeks, Playtika Holding Corp. has reported past-year improvements in revenue and net profit alongside stable financial health, while also extending the lifecycles of key mobile titles through licensed collaborations such as Bingo Blitz’s Where’s Waldo? rooms and a coral reef protection event in Solitaire Grand Harvest. An interesting angle for investors is the recent quarter-over-quarter rise in institutional ownership, which points to growing professional interest in Playtika’s...
NasdaqGS:HFWA
NasdaqGS:HFWABanks

Will Profit Gains And Higher Institutional Ownership Change Heritage Financial's (HFWA) Narrative?

In recent months, Heritage Financial Corp reported strong year-over-year growth in quarterly revenue and net profit, even as operating efficiency remained low. At the same time, institutional ownership rose meaningfully to over four-fifths of shares outstanding, indicating increasing participation from professional investors. We’ll now examine how this combination of robust profit growth and rising institutional ownership may influence Heritage Financial’s existing investment narrative. The...
NasdaqGS:STRA
NasdaqGS:STRAConsumer Services

Strategic Education (STRA) Stock Could Be 13.4% Undervalued After Institutional Buying And Growth

Recent commentary around Strategic Education (STRA) focuses on two linked developments: a sharp rise in institutional ownership and year over year growth in both revenue and net profit, which together are shaping current sentiment on the stock. See our latest analysis for Strategic Education. At a share price of $75.33, Strategic Education has experienced a decline in its short term share price return, with the 30 day share price return down 4.42% and the year to date share price return down...
NasdaqCM:PCT
NasdaqCM:PCTChemicals

What PureCycle Technologies (PCT)'s New Jersey PCR Approval Means For Shareholders

Earlier this month, PureCycle Technologies announced that New Jersey regulators confirmed its PureFive resin qualifies as post-consumer recycled content for food-contact packaging, with Amcor already producing rigid containers containing at least 20% PureFive to align with the state’s upcoming mandates. This regulatory validation positions PureCycle as a ready-made solution provider for brands facing tightening recycled content rules in food packaging, especially as mandates ratchet higher...
NYSE:H
NYSE:HHospitality

Hyatt Hotels (H) Stock Could Be 4.4% Overvalued After New Expansion Agreements

Recent expansion moves and what they mean for Hyatt Hotels stock Hyatt Hotels (H) has been active on the development front, with a new management agreement for Hyatt Place Semarang in Indonesia and the planned conversion of the Ontario Airport Hotel into a Hyatt Regency. These agreements expand Hyatt Hotels' presence in Southeast Asia and Southern California, and give investors fresh projects to watch as the company continues to grow its management and franchising footprint alongside its...
NYSE:SNDR
NYSE:SNDRTransportation

Schneider National (SNDR) Stock Could Be 26% Overvalued After Resilient Demand Update

Schneider National (SNDR) shares are in focus after executives reported stable demand across key customers, even as lending sensitive sectors felt pressure and overall freight volumes remained lower. See our latest analysis for Schneider National. Schneider National’s recent comments on resilient demand and revenue near prior highs come as the stock trades at US$35.68, with a 30 day share price return of 7.02% but a 7 day decline of 7.18%, while the 1 year total shareholder return of 52.77%...
NYSE:TNK
NYSE:TNKOil and Gas

Does Stronger Fundamentals And Rising Institutional Ownership Change The Bull Case For Teekay Tankers (TNK)?

In recent days, Teekay Tankers reported very strong financial health, with year-over-year revenue and net profit rising significantly alongside high operating efficiency and growth scores. This upbeat fundamental picture has coincided with increased institutional ownership and reinforced bullish analyst sentiment, including favorable earnings estimate revisions and positive technical signals. We’ll now examine how this improved financial health and institutional interest may reshape Teekay...
NasdaqGS:TOWN
NasdaqGS:TOWNBanks

How TowneBank’s Mixed Quarter And Partnership Push At TowneBank (TOWN) Has Changed Its Investment Story

TowneBank recently reported a mixed quarterly update, with revenues coming in slightly below analyst expectations while management emphasized resilient balance sheet strength and disciplined risk management amid macroeconomic challenges. The bank also highlighted progress on integrating new partnerships, recruiting talent, and expanding its product offering, underlining how operational initiatives are intended to support earnings durability over time. Next, we’ll examine how TowneBank’s...
NasdaqGS:SBUX
NasdaqGS:SBUXHospitality

Starbucks (SBUX) Stock After 20% Year To Date Gain Is There Still Upside

If you are wondering whether Starbucks stock still offers value after its recent run, this article breaks down what the current price might be implying about the company. Starbucks shares last closed at US$100.65, with the stock down 2.3% over the past week and 3.3% over the past month, but up 19.9% year to date and 10.9% over the past year. Recent commentary around Starbucks has focused on how the stock's year to date and one year returns compare with its longer term 3 year and 5 year...
NasdaqGS:TSHA
NasdaqGS:TSHABiotechs

Why Taysha Gene Therapies (TSHA) Is Up 12.4% After Institutions Tighten Their Grip On Shares

In recent days, Taysha Gene Therapies reported that institutional investors now hold just over all of its shares, with firms like Morgan Stanley, BlackRock, State Street, and others increasing their positions while technical indicators moved to a Buy stance with multiple supportive moving-average signals. This combination of concentrated institutional ownership and technically positive trading signals highlights how professional investors and short-term traders are converging on the stock at...
NYSE:GNRC
NYSE:GNRCElectrical

3 Power Grid Stocks With Strong Backlogs And Profit Margin Questions

Global inflation questions, shifting rate expectations and uneven growth across major economies are keeping investors focused on companies that sit at the core of real-world infrastructure. Power Grid Technology Stocks stand out in this setting because they are linked to the essential hardware and services that keep electricity flowing to AI data centers, factories and homes. With the aging grid under pressure from electrification and energy demand, this screener filters for established,...
NYSE:AGCO
NYSE:AGCOMachinery

AGCO (AGCO) Stock Could Be 11.6% Undervalued After Valtra Production Milestone

AGCO’s Valtra Milestone Puts Manufacturing Investment in Focus AGCO (AGCO) drew investor attention after its Valtra brand produced the 1,000th continuously variable transmission at its Suolahti, Finland factory. This marks a key step in a €38 million powertrain manufacturing investment. See our latest analysis for AGCO. At a share price of $113.66, AGCO has posted a 7.39% year to date share price return and a 12.30% total shareholder return over one year, while the 3 year total shareholder...
NYSE:ENR
NYSE:ENRHousehold Products

Energizer Holdings (ENR) Stock Could Be 76.8% Below Fair Value As Institutions Circle

Institutional Interest Rises as Energizer Holdings Draws Fresh Scrutiny Recent data shows Energizer Holdings (ENR) attracting increased institutional ownership that now leads its peer group, even as weak financial health and sharply lower recent profits and revenue keep risk firmly in focus. See our latest analysis for Energizer Holdings. Energizer Holdings’ recent 24.39% 1 month share price return and 28.79% 3 month share price return suggest momentum has picked up, although the 5 year total...
NYSE:AMBP
NYSE:AMBPPackaging

Ardagh Metal Packaging (AMBP) Stock Could Be 4% Undervalued After Revenue And Profit Growth

Recent analysis of Ardagh Metal Packaging (AMBP) highlights year-over-year revenue growth of 18.61% and net profit growth of 54.55%, drawing attention even as its overall financial status is described as weak. See our latest analysis for Ardagh Metal Packaging. At a share price of $4.34, Ardagh Metal Packaging has seen a 10.71% 90 day share price return, while the 1 year total shareholder return of 15.36% suggests momentum has been building despite earlier longer term weakness. If this kind...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

How Strong Pediatric CASGEVY Data Could Impact Vertex Pharmaceuticals’ (VRTX) Gene Therapy Investment Narrative

Vertex Pharmaceuticals recently reported Phase 3 data showing that its CRISPR-based gene therapy CASGEVY produced consistent efficacy and safety in children ages 5–11 with severe sickle cell disease and transfusion-dependent beta thalassemia, with all evaluable patients meeting key endpoints over at least 12 months of follow-up. By extending CASGEVY’s transformative clinical profile into younger pediatric patients and progressing regulatory reviews to broaden its label, Vertex is signaling a...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

Arrowhead Pharmaceuticals (ARWR) Stock Could Be 25.6% Undervalued After R And D Webinar Update

Arrowhead Pharmaceuticals (ARWR) recently outlined a Summer Series of R&D webinars focused on its cardiometabolic pipeline, alongside positive clinical updates and upcoming regulatory milestones that have drawn fresh attention to the stock. See our latest analysis for Arrowhead Pharmaceuticals. Arrowhead Pharmaceuticals’ recent R&D webinar announcement and positive late May clinical readouts have coincided with strong momentum, including a 45.25% 3 month share price return and a very large 1...
NYSE:SSD
NYSE:SSDBuilding

Simpson Manufacturing (SSD) Stock Could Be 8.1% Undervalued After Housing Data And Earnings Strength

Simpson Manufacturing (SSD) stock moved higher after U.S. pending home sales improved and mortgage rates eased slightly, which lifted housing affordability and trading interest just as the company reports higher revenue and net profit. See our latest analysis for Simpson Manufacturing. The latest move builds on a broader positive pattern for Simpson Manufacturing, with a 1 month share price return of 8.4% and year to date share price return of 21.5%. The 1 year total shareholder return of...
NasdaqCM:VKTX
NasdaqCM:VKTXBiotechs

Viking Therapeutics (VKTX) Stock Could Be 67.2% Undervalued After Analysts Back VK2735

Executive change adds experience to Viking Therapeutics' clinical ambitions Viking Therapeutics (VKTX) recently drew fresh attention after analyst reports highlighted the potential of obesity drug candidate VK2735, and the company added further depth by appointing Hubert C. Chen, M.D., as chief medical officer. For investors watching Viking Therapeutics stock, Dr. Chen’s background across drug discovery, clinical development, and regulatory strategy adds another layer to the story around...
NasdaqGS:SMCI
NasdaqGS:SMCITech

Super Micro’s US$5 Billion Equity Raise To Fund AI Backlog Could Be A Game Changer For SMCI

Earlier in June 2026, Super Micro Computer completed a US$1.25 billion common stock follow-on offering and a US$3.75 billion mandatory convertible preferred share issue, as part of a broader plan to raise up to US$7 billion to fund a large AI server order backlog. This financing wave, enabled by new shelf registrations and at-the-market facilities, highlights how Super Micro is leaning on equity-linked capital rather than traditional debt amid governance and regulatory constraints. With this...
NYSE:C
NYSE:CBanks

Citigroup (C) Stock Could Be 2.6% Undervalued After Basel III Relief

The recent move in Citigroup (C) stock is closely tied to the Federal Reserve’s decision to soften Basel III capital requirements, along with renewed investor focus on the bank’s multi year restructuring and capital return plans. See our latest analysis for Citigroup. Citigroup’s recent 14.25% 1 month share price return and 30.62% 3 month share price return, on a last close of $143.06, sit alongside a very large 3 year total shareholder return of 242.97%. This suggests momentum has been...